Stock Analysis

JADE BIOSCIENCES INC (JBIO)

Loading... + Investors. Track Smart Money conviction in JBIO. See who's accumulating, reducing, or initiating positions.

Loading...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +28
Streak
3Q ▲
Buyers last Q
80%

Smart Money Signals — JBIO

Based on 93 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added this stock than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term trade.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
93 hedge funds hold this stock right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a 'crowded trade' — high ownership doesn't mean safe.
🚀

Fast accumulation — +9200% more funds vs a year ago

fund count last 6Q
+92 new funds entered over the past year (+9200% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 80% buying

69 buying17 selling
Last quarter: 69 funds were net buyers (33 opened a brand new position + 36 added to an existing one). Only 17 were sellers (12 trimmed + 5 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+26 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 0 → 60 → 7 → 33. A growing number of new institutional buyers means the stock is still being discovered — the opportunity hasn't been fully priced in.
🔄

Mostly new holders — 91% entered in last year

3% conviction (2yr+) 5% medium 91% new
Only 3 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +167% but shares only +49% — price-driven

Value
+166%
Shares
+49%
Last quarter: the total dollar value of institutional holdings rose +167%, but actual share count only changed +49%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📊

Peak discovery — momentum slowing

1 → 0 → 60 → 7 → 33 new funds/Q
New funds entering each quarter: 0 → 60 → 7 → 33. The stock is well-known in the hedge fund world but new entries are declining. The easy phase of institutional discovery may be behind us.
🌱

Early stage — 91% of holders entered in last year

9% veterans 0% 1-2yr 91% new
Of 94 current holders: 86 (91%) entered in the past year, only 8 (9%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

Strong quality — 23% from major AUM funds

23% from top-100 AUM funds
21 of 93 current holders rank in the top 100 by AUM. A meaningful share of the ownership base comes from the most well-resourced institutions.
7.3
out of 10
High Exit Risk
Exit risk score 7.3/10 — multiple crowding signals converge. Institutional ownership is at 100% of its all-time high. Crowded trades can unwind fast — a single catalyst can trigger a cascade.

Hedge Fund Ownership: JBIO

How many hedge funds hold JBIO — quarterly history vs. share price
Quarterly hedge fund ownership of JBIO vs. share price

Market Analysis: JBIO

View More

Analyst Price Targets

-- Low
-- High
-- Average
-- Current

Analyst Recommendations

Stock Performance

Real-time

Company Profile: JBIO

-- --
Hedge Fund Positioning: JBIO
Loading... + Investors

Track Smart Money conviction in JBIO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change

Statistics: JBIO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --
Institutional Holders (2025 Q4)
Loading... + investors

Track Smart Money conviction in JBIO. See who's accumulating, reducing, or initiating positions.

Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy
Price
13F Score™ 3Y / 7Y Shares Mkt Value Change Change % Source Quarter Filed